{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:37:09Z","timestamp":1784029029572,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NHS Research Scotland"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.lungcan.2016.07.020","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T19:25:29Z","timestamp":1469129129000},"page":"194-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study"],"prefix":"10.1016","volume":"99","author":[{"given":"Hongjiang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Damhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Brewster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2016.07.020_bib0005","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/thoraxjnl-2013-203744","article-title":"Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma","volume":"69","author":"Lacourt","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1289\/ehp.8562319","article-title":"Health implications of environmental exposure to asbestos","volume":"62","author":"McDonald","year":"1985","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0015","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L","article-title":"Latency of asbestos disease among insulation workers in the United States and Canada","volume":"46","author":"Selikoff","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0020","first-page":"319","article-title":"Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health","volume":"110","author":"Neumann","year":"2013","journal-title":"Deutsches Arzteblatt Int."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00001622-199104000-00014","article-title":"Pleural mesothelioma","volume":"3","author":"Ruffie","year":"1991","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(95)90462-X","article-title":"Continuing increase in mesothelioma mortality in Britain","volume":"345","author":"Peto","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2013.05.014","article-title":"The role of epigenetics in malignant pleural mesothelioma","volume":"81","author":"Vandermeers","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0040","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.bjc.6602611","article-title":"Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study","volume":"92","author":"Swerdlow","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0045","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/dc09-1721","article-title":"Postoperative mortality in cancer patients with preexisting diabetes systematic review and meta-analysis","volume":"33","author":"Barone","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0050","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1001\/jama.2008.824","article-title":"Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis","volume":"300","author":"Barone","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/jsre.2002.6449","article-title":"The need for a multidisciplinary approach to cancer care","volume":"105","author":"Ko","year":"2002","journal-title":"J. Surg. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.lungcan.2016.07.020_bib0060","first-page":"S4","article-title":"Executive summary: standards of medical care in diabetes\u20142012","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0065","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-09-1186","article-title":"Metformin in cancer therapy: a new perspective for an old antidiabetic drug","volume":"9","author":"Ben Sahra","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0070","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"DeCensi","year":"2010","journal-title":"Cancer Prevent. Res."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0075","doi-asserted-by":"crossref","first-page":"e33411","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis","volume":"7","author":"Noto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0080","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: time-related biases in observational studies","volume":"35","author":"Suissa","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0085","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/bjc.2013.187","article-title":"Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK","volume":"108","author":"Storozhuk","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"Suppl. 6","key":"10.1016\/j.lungcan.2016.07.020_bib0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0959-8049(14)70331-4","article-title":"Metformin to modulate AMP-kinase and enhance chemotherapy and radiotherapy in non-small cell lung cancer","volume":"50","author":"Troncone","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0095","doi-asserted-by":"crossref","first-page":"S656","DOI":"10.1016\/j.ijrobp.2014.05.1939","article-title":"Preclinical studies of metformin reveal radiosensitization for human small cell lung cancer in vitro but apparent antagonism in vivo","volume":"90","author":"Rabin","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0100","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1634\/theoncologist.2013-0111","article-title":"Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis","volume":"18","author":"Yin","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0105","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1002\/cncr.26151","article-title":"Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes","volume":"117","author":"Tan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/1471-2407-12-410","article-title":"The effect of metformin and thiazolidinedione use on lung cancer in diabetics","volume":"12","author":"Mazzone","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0115","first-page":"346","article-title":"Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation","volume":"7","author":"Ahmed","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0120","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1164\/rccm.201407-1395OC","article-title":"Survival of patients with stage IV lung cancer with diabetes treated with metformin","volume":"191","author":"Lin","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12094-015-1311-1","article-title":"Prognosis of small cell lung cancer patients with diabetes treated with metformin","volume":"17","author":"Xu","year":"2015","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1464-5491.2008.02453.x","article-title":"Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 2001\u20132006","volume":"25","author":"McKnight","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0135","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00125-015-3492-0","article-title":"Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland","volume":"58","author":"Malik","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0140","unstructured":"Information Services Division, http:\/\/www.isdscotland.org\/Health-Topics\/Cancer\/Cancer-Statistics\/Lung-Cancer-and-Mesothelioma\/#mesothelioma, (accessed 3.03.16.)."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0145","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ijc.26421","article-title":"The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus","volume":"131","author":"Lee","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/EDE.0b013e3182093a0f","article-title":"Time-window bias in case-control studies: statins and lung cancer","volume":"22","author":"Suissa","year":"2011","journal-title":"Epidemiology"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0155","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1440-1746.2011.06664.x","article-title":"Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation","volume":"26","author":"Chen","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0160","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.2337\/dc12-2535","article-title":"Association between metformin therapy and mortality after Breast cancer: a population-based study","volume":"36","author":"Lega","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0165","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2012.46.7043","article-title":"Metformin use and all-cause and prostate cancer\u2013specific mortality among men with diabetes","volume":"31","author":"Margel","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0170","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/1055-9965.EPI-13-0347","article-title":"A cohort study of metformin exposure and survival in patients with stage I\u2013III colorectal cancer","volume":"22","author":"Spillane","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prevent."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0175","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0180","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(09)70134-2","article-title":"A review of human carcinogens\u2014part C: metals, arsenic, dusts, and fibres","volume":"10","author":"Straif","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2016.07.020_bib0185","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1179\/oeh.2007.13.3.318","article-title":"Asbestos exposure causes mesothelioma, but not this asbestos exposure: an amicus brief to the Michigan Supreme Court","volume":"13","author":"Welch","year":"2007","journal-title":"Int. J. Occup. Environ. Health"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0190","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/19338241003776104","article-title":"Asbestos is still with us: repeat call for a universal ban","volume":"65","author":"Ramazini","year":"2010","journal-title":"Arch. Environ. Occup. Health"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-publhealth-031811-124704","article-title":"The worldwide pandemic of asbestos-related disease","volume":"34","author":"Stayner","year":"2013","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.lungcan.2016.07.020_bib0200","unstructured":"World Health Organization, Asbestos: elimination of asbesto-related diseases. 2014."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500216304184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500216304184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T01:50:11Z","timestamp":1589680211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500216304184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":40,"alternative-id":["S0169500216304184"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2016.07.020","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2016.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}